PMID: 6109866Jan 24, 1981Paper

Hypercalcaemia in hospital patients. Clinical and diagnostic aspects

Lancet
R A FiskenA M Bold

Abstract

The relative importance of different causes of hypercalcaemia was studied, and diagnostic tests were evaluated as predictors of the cause of hypercalcaemia. In one year, hypercalcaemia was identified in 166 hospital inpatients. Serum-calcium was below 3.00 mmol/l in 63%. Among 153 patients investigated the commonest cause of hypercalcaemia was malignancy (89 cases), especially breast and bronchial tumours. 75% of the 89 patients had obvious metastases at presentation. 51 patients had primary hyperparathyroidism: their symptoms were non-specific and only 20% had renal stones. Other causes of hypercalcaemia were rare (9% of patients seen). Of patients with no diagnosis initially, 64% had hyperparathyroidism and 32% malignancy, but this was demonstrated early in the illness. Serum phosphate and chloride and acid/base status were unsatisfactory as diagnostic tests; multivariate analysis was more discriminating overall, but incorrect classification was still a significant problem.

References

Mar 1, 1978·Annals of Internal Medicine·J W Jefferson
Apr 1, 1978·Clinical Endocrinology·V Lo CascioL A Scuro
Jul 1, 1978·American Journal of Surgery·G W PeskinR P Saik
May 1, 1966·Medicine·F W Lafferty
Jan 1, 1967·The Journal of Clinical Endocrinology and Metabolism·L M SherwoodJ T Potts
Jan 1, 1980·The Journal of Clinical Endocrinology and Metabolism·L E Mallette
Jun 14, 1980·British Medical Journal·D A HeathN J Dorricott

❮ Previous
Next ❯

Citations

Oct 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·F W Lafferty
Oct 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D A Heath, E M Heath
Mar 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·H A Harvey
Jan 1, 1992·Intensive Care Medicine·H E van der WielL G Thijs
Nov 1, 1988·Irish Journal of Medical Science·F P MuldowneyM J McKenna
Aug 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·A G NeedB E Nordin
Dec 31, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·D A Lacher
Mar 2, 1985·Lancet·P M Kaye, D J Oliver
Apr 13, 1985·Lancet·S H RalstonI T Boyle
Aug 1, 1996·Hematology/oncology Clinics of North America·Y M Barri, J P Knochel
Jan 29, 1983·British Medical Journal·D J Hosking
Jun 9, 1984·British Medical Journal·S G AllanJ F Smyth
Feb 2, 1985·British Medical Journal·M J Jamieson
Jun 3, 1989·BMJ : British Medical Journal·D A Heath
May 16, 1992·BMJ : British Medical Journal·I GreavesD Adu
Jul 1, 1982·Journal of Clinical Pathology·R M FrancisC Gray
Jul 11, 1998·Journal of Clinical Pathology·L RanganathP F Goddard
Sep 1, 1987·Postgraduate Medical Journal·D M DentJ Barron
Aug 30, 2001·Critical Care Clinics·M Kapoor, G Z Chan
Jul 17, 2001·Journal of Internal Medicine·O LamyP Burckhardt
May 10, 2001·International Journal of Hematology·M R El-SonbatyA Abdulrazak
Sep 1, 1983·The British Journal of Surgery·P J Billings, E J Milroy
Jul 11, 1998·Journal of Clinical Pathology·J E Trowell, G D Bell
Jul 1, 1992·World Journal of Surgery·B NiederleR Prager
Jan 1, 1984·Critical Reviews in Clinical Laboratory Sciences·K R JohnsonA T Howarth
Mar 1, 1990·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D ThiebaudP Burckhardt
Jan 1, 1988·Clinical and Laboratory Haematology·A W ChanM T Haqqani
Sep 1, 1984·Journal of the Royal Society of Medicine·A Rajathurai, R Cove-Smith
Oct 1, 1994·American Journal of Hematology·A M Jasek, H J Day
Sep 1, 1996·Acta Anaesthesiologica Scandinavica·H Breivik
May 1, 1993·Scandinavian Journal of Clinical and Laboratory Investigation·A FrølichP McNair
Jan 1, 1986·Acta Medica Scandinavica·C P Blomqvist
Nov 21, 1997·Annals of Clinical Biochemistry·J P AshbyS M Gow
Jan 1, 1982·Annals of Clinical Biochemistry·M R Holland, A G Jacobs
Jan 31, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·A Segura DomínguezR V García-Mayor
Oct 1, 1989·Current Problems in Pediatrics·G Kainer, J C Chan
Mar 16, 2006·The American Journal of the Medical Sciences·Chien-Te LeeHung-Chun Chen
Jun 1, 1997·Current Problems in Surgery·F K ChanJ P Bilezikian
Feb 1, 1985·Clinics in Endocrinology and Metabolism·A de Bustros, S B Baylin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
F W Lafferty
Journal of Analytical Toxicology
Thomas C KupiecVishnu Raj
© 2021 Meta ULC. All rights reserved